Iran to receive 3 million doses of COVAX vaccine in coming days
TEHRAN – The representative of the World Health Organization (WHO) in Iran, Jaffar Hussain, has announced that three million doses of the vaccine will soon be delivered to the country as part of the COVAX facility.
The COVAX facility is a partnership co-led by the Coalition for Epidemic Preparedness Innovations (CEPI), Gavi-The Vaccine Alliance and WHO, alongside a key partner of the United Nations Children’s Fund (UNICEF).
Iran has purchased 16.8 million doses, while around 5.8 million doses have already arrived in the country, and three million are expected to receive within the next few days, he said.
Iran has purchased 16.8 million doses of vaccine as part of the COVAX facility.Other countries can also donate vaccines through the COVAX facility, such as Japan which will provide nearly 3 million doses of vaccine to Iran, Hossein said.
Hossein visited a COVID-19 vaccination center in Tehran on Wednesday and injected a vaccine into one of the clients.
Iran received the first shipment of COVAX vaccines, comprising more than 700,000 doses of Oxford AstraZeneca vaccine manufactured by South Korean company SK Bioscience, and the second consisted of 1,452,000 doses of AstraZeneca vaccine manufactured by Catalent Anagni d ‘Italy.
Earlier in August, Hussain released a statement, saying it is encouraging to see an acceleration of coronavirus vaccination in Iran which began in early August.
WHO greatly recognizes the recent increase in the frequency of vaccinations following the deployment of international and locally manufactured vaccines.
FB / MG